IPCALAB:NSE
IPCA Laboratories Ltd
₹1,912.00
arrow_downward
-1.36%(-26.40) 1D
Oct 9, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPCALAB...
Open
₹1,942.90
High
₹1,952.50
Low
₹1,905.00
Mkt. cap
485.08B
Avg. vol.
246.80K
Volume
94.28K
Dividend
0.31%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
37.03
52-wk high
₹2,038.00
52-wk low
₹1,251.60
EPS
₹51.63
Shares outstanding
126.35M
No. of employees
17K
Open
₹1,942.90
High
₹1,952.50
Low
₹1,905.00
Mkt. cap
485.08B
Avg. vol.
246.80K
Volume
94.28K
Dividend
0.31%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
37.03
52-wk high
₹2,038.00
52-wk low
₹1,251.60
EPS
₹51.63
Shares outstanding
126.35M
No. of employees
17K
News stories
From web sources and news partners
富途牛牛
·
22 minutes ago
Beneath the S&P 500's record highs lie hidden risks: most constituent stocks are underperforming, while soaring oil prices and rising U.S. Treasury yields are further widening market divergence.
MarketBeat
·
1 hour ago
PTC Therapeutics (NASDAQ:PTCT) Director Sells 2,500 Shares of Company Stock
Yahoo Finance
·
1 hour ago
S&P 500, Nasdaq 100, Dow End Week Higher With Traders Eyeing Earnings Season — MSFT, NFLX, SPCX, ASTS In Focus
Nasdaq
·
11 hours ago
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
About IPCA Laboratories Ltd